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In the hair follicle, the dermal papilla (DP) and dermal sheath (DS) support and maintain proliferation and differentiation of the
epithelial stem cells that produce the hair fibre. In view of their regulatory properties, in this study, we investigated the interaction
between hair follicle dermal cells (DP and DS) and embryonic stem cells (ESCs); induced pluripotent stem cells (iPSCs); and
haematopoietic stem cells. We found that coculture of follicular dermal cells with ESCs or iPSCs supported their prolonged
maintenance in an apparently undifferentiated state as established by differentiation assays, immunocytochemistry, and RT-PCR
for markers of undifferentiated ESCs. We further showed that cytokines that are involved in ESC support are also expressed by
cultured follicle dermal cells, providing a possible explanation for maintenance of ES cell stemness in cocultures. The same
cytokines were expressed within follicles in situ in a pattern more consistent with a role in follicle growth activities than stem
cell maintenance. Finally, we show that cultured mouse follicle dermal cells provide good stromal support for haematopoiesis in
an established coculture model. Human follicular dermal cells represent an accessible and readily propagated source of feeder
cells for pluripotent and haematopoietic cells and have potential for use in clinical applications.
1. Introduction
Adult hair follicle dermal cell populations have extensive
regenerative, inductive, and supportive capabilities, both
within adult and developing hair follicles [1, 2] and in com-
bination with other cell types including cornea and amnion
[3, 4]. Experimentally, subpopulations of adult hair follicle
dermal cells have demonstrated extensive stem cell capabil-
ities, and multipotency, including generation of bone, fat,
and muscle in vitro [5–7]. Additionally, dermal cells can
differentiate down a haematopoietic lineage both in vivo
and in vitro, [8, 9] and have characteristics similar to
embryonic neural crest stem cells [10]. In this respect, they
behave similarly to stem cell populations isolated from
adult bone marrow, a common source of adult stem cells
[11]. It is interesting to note that cells isolated from adult
bone marrow also have supportive capabilities, particularly
in the support of hematopoietic stem cells and embryonic
stem cells (ESCs) in vitro [12–14]. Bone marrow cells sup-
port epidermal keratinocytes in in vitro skin reconstitution
assays [15] and during cutaneous wound healing [16], dem-
onstrating significant similarities with hair follicle dermal
cells [17, 18].
ESCs, derived from the inner cell mass of mammalian
blastocysts [19–21], retain their developmental potential
after prolonged culture to differentiate down all three germ
layer lineages in vivo and in vitro. Induced pluripotent stem
cells (iPSCs), which are almost comparable to ESCs, are gen-
erated by reprogramming somatic cells, a process initially
achieved using virus-mediated gene transduction of a few
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key factors [22, 23]. While mouse ESCs (mESCs) can be con-
tinuously cultured without feeder cells on gelatin-coated
plates with the addition of leukemia inhibitory factor (LIF)
[24], human ESCs (hESCs) or iPSCs will differentiate in
culture in the presence of this cytokine. Propagation of
undifferentiated human ESCs or iPSCs is commonly carried
out by coculture with a mouse embryonic fibroblast (MEF)
feeder layer. To improve the potential clinical utility of
human pluripotent cells, considerable progress has been
made in establishing defined feeder-free culture systems
for hESCs or iPSCs [25–27], with methods that include
growing the cells on specific substrates [28, 29], in suspension
cultures [30] or in defined serum-free medium [31]. Another
approach has been to replace MEFs with human-derived
cells. For example, bone marrow stromal cells (BMSC) [13],
neonatal skin fibroblasts, stromal cells [32–34], amniotic
mesenchymal cells [35], or human foetal cell lines [36] have
all been employed as feeder cells. However, the use of human
feeder layers requires that the feeder cell type is easily acces-
sible, readily propagated, and efficient at maintaining and
amplifying undifferentiated hESCs suitable for clinical use.
Interactions between adjacent cells of different types are a
major mechanism of organogenesis in developmental biology.
In view of the inductive properties of hair follicle dermal cells
[1, 2], we initially set out to investigate their effects on mESCs
by coculture in vitro, anticipating that the dermal cells would
exert some directive influence on mESC differentiation. How-
ever, we found that follicular dermal cells appeared to be effec-
tive in maintaining the mESCs in an undifferentiated state.
This was confirmed by inducing differentiation of the mESCs
along multiple lineages after prolonged coculture and by
investigating the expression of markers characteristic of undif-
ferentiated mESCs by RT-PCR and immunofluorescence. We
subsequently investigated the mechanism by which dermal
cultures may be able to support mESCs by examining the
expression of members of the IL-6 family of cytokines, known
to be crucial for maintainingmurine embryonic stem cell plur-
ipotency in vitro via the gp130 receptor and the JAK/STAT
pathway. Parallel investigations were also performed on folli-
cles, based on the hypothesis that follicle epithelial stem cells
might be maintained in an undifferentiated state by ES cell-
typemechanisms. This was not supported by the observations,
but the prevalence of IL-6 family cytokines and the gp130
receptor in follicles did point to a functional role of gp130/
JAK/STAT signalling in hair follicle activities.When the ability
of human hair follicle dermal cells to maintain hESCs and
hiPSCs in an undifferentiated state was assessed, it was con-
firmed that like their rodent cell counterparts, the follicle der-
mal cells were superior to skin fibroblasts in their ability to
maintain and support hESC and iPSC cultures. Finally, given
the apparent similarities between bone marrow stromal cells
and hair follicle dermis/mesenchyme [17], we performed
coculture experiments to investigate the ability of hair follicle
dermal cells to support haematopoietic activity. Here again,
the follicle cells were the equal if not better than bone
marrow-derived stromal cells under the experimental condi-
tions employed.
These observations have implications for the regulation
of both dermal and epithelial stem cells in the hair follicle,
as well as confirming that hair follicle dermal cells have the
potential to be a useful source of feeder cells for the support
and amplification of a range of stem cell types.
2. Materials and Methods
2.1. Hair Follicle DP and DS Cell Isolation and Culture. DP
and DS were microdissected from the vibrissa follicles of
adult PVG rats or BalbC or Zin40 mice as previously
described [37]. Animal tissues were obtained from animals
housed in accordance with the institutional guidelines at
the University of Durham. Human DP and DS were micro-
dissected from skin biopsies as previously described [2], with
skin biopsies obtained as anonymised discarded tissue in
accordance with Helsinki guidelines. Skin dermal fibroblast
(SF) cultures were established as explants from finely minced
rodent footpad or human interfollicular scalp skin. A sponta-
neously transformed rat dermal papilla cell line, RDP-B [38],
was also used as a control line. Once established, cells were
maintained in MEM (Sigma) supplemented with 10% FBS
(Gibco) and antibiotics (Sigma) (dermal cell medium) at
37°C, 5% CO2, with passaging every 2–4 weeks.
2.2. Mouse ESC Culture. Mouse CGR8 ESCs were routinely
cultured on mitomycin C-inactivated MEF feeder layers in
Glasgow MEM supplemented with 10% FBS, 100μM β-mer-
captoethanol (Gibco), 2mM L-glutamine, 1% nonessential
amino acids, 0.25% NaHCO3, 1mM pyruvate (Sigma), and
1000U/ml LIF (Chemicon) (mESC medium). Cells were
grown on 0.1% gelatin (Sigma) coated 6-well plates and split
at ratios from 1 : 3 and 1 : 6 to 1 : 8 prior to becoming conflu-
ent. Two CGR8 cell lines transfected with GFP-expressing
vectors were used in various assays; one designated CGR8-
GFP, expressed GFP from a CAGG promoter which escaped
silencing in mESCs, and was used to track both differentiated
and undifferentiated mESCs in cocultures, while the second
designated CGR8 Rex1-EGFP, expressed GFP under the con-
trol of the Rex-1 promoter, and was used to localize undiffer-
entiated mESCs in cocultures. mESCs were stably transfected
with the Rex 1-EGFP vector (a kind gift from Dr. N. Benve-
nisty) [39], using TransFast (Promega) in accordance with
the manufacturer’s protocol. CGR8 Rex1-EGFP cells were
routinely maintained onMEF feeder layers in mESCmedium
with periodic reselection by addition of 400μg/ml G418 to
the culture medium.
2.3. 2D Coculture of mESCs with Rodent Dermal Cells. The
CGR8 Rex1-EGFP and CGR8-GFP cells were used for
coculture experiments. Initially, rodent DP, DS, or SF cells
were plated at 4 × 105 cells per well of 6-well culture plates
(the same cell density as MEFs for feeder layers). Subconflu-
ent mESCs were then seeded over the feeder layer in each
well. The rodent cocultures were passaged every two days
with a splitting ratio of 1 : 6. A second set of experiments
was performed in which rodent DP or DS monolayers were
established in 35mm culture dishes, and 500, 3000, 5000,
or 10,000 Rex 1-EGFP mESCs were added to each dish when
the dermal layer reached 80% confluence. These cocultures
were then maintained for up to 4 weeks without splitting. A
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third set of cocultures was also performed but dermal cells
were physically separated from mESCs by seeding them on
porous membrane inserts (0.45μm pore size, Falcon), placed
over 6-well plates containing mESCs.
All cocultures were routinely maintained in dermal cell
medium, without the addition of LIF, but some samples were
also grown in ESC differentiation medium (mESC medium
without LIF). At least 3 sets of dermal/ES cell cocultures were
established, and in the case of the hair follicle dermal cells,
experiments were repeated at least 6 times. Dermal cells used
were between passage 2 and passage 7 with over 30% of them
at passage 1 to passage 3.
2.4. Culture of mESCs with Dermal Cell-Conditioned
Medium. To obtain conditionedmedium, rodent dermal cells
or dermal/ES cell cocultures were incubated with dermal cell
medium for 48 hours. After this, time medium was collected
and centrifuged (30min, 3300 rpm) to remove cell debris and
the supernatant were stored at −20°C for future use. mESCs
were then cultured for 10 days in conditioned medium
(CM) diluted 1 : 1 with ESC differentiation medium. The
morphology of these cells was compared to mESCs cultured
for the same period in mESC medium with or without LIF.
2.5. 3D Coculture of Rodent Cells. CGR8 mESCs and PVG
rat DP or DS cells were mixed in three different ratios of
mESC : dermal cells (1 : 1, 1 : 3, and 1 : 10). 3D cultures were
generated using a hanging drop method; 10μl drops of
cell suspension in ESC differentiation medium containing
approximately 400 mixed cells were placed on the lids of
bacteriological Petri (nontissue culture-treated) dishes filled
with phosphate buffered saline (PBS). Several sets of cocul-
tures utilized follicular dermal cells stained with DiI and
CGR8-GFP mESCs so that the mESC and follicular dermal
cells could be distinguished in mixed cultures. After cultiva-
tion for 3 days, the aggregates were transferred into bacterio-
logical Petri dishes and maintained in suspension in ESC
differentiation medium. Differentiation was investigated by
microscopy, immunofluorescence, and RT-PCR of the
embryoid-like bodies after a further 9 days of culture.
2.6. Differentiation of mESC Cultures. CGR8-GFP mESCs
were isolated from cocultures with DP or DS cells. The
medium was removed from the cocultures and the cells were
washed twice with PBS. A 30μl volume of TVP solution
(trypsin, versene, and chick plasma; Sigma) was taken up in
a 200μl automatic pipette tip and repeatedly expelled and
aspirated over a small area of the coculture until gaps could
be seen in the cell layer. The contents of the tip were then
expelled into a gelatin-coated 35mm culture dish, and the
cells were briefly expanded in mESC medium prior to being
plated at 0.54 × 106 cells per 90mm bacteriological Petri dish
to generate EBs. After a short suspension period, EBs could
be observed; medium was changed every 2 days by centrifug-
ing EBs for 3 minutes at 800 rpm and resuspending in fresh
ESC differentiation medium. EBs were then exposed to dif-
ferent conditions to promote differentiation.
2.6.1. Neuronal Differentiation Assay. 4 days after EB estab-
lishment, all-trans-retinoic acid (Sigma), diluted in ESC
differentiation medium, was added to the suspension cultures
(at a final concentration of 10−7M). This was repeated on day
6. By day 8, approximately 50 EBs were transferred to gelatin-
coated 60mm dishes and incubated with ESC differentiation
medium without β-mercaptoethanol (prohibits differentia-
tion and is left out of the medium from this stage) for 2 days.
18μM cytosine arabinoside (Ara-C) was added on day 10
and the dishes were incubated for a further 2 days to optimize
neuron-like cell numbers [40]. Immunocytochemistry was
carried out on differentiated cells (day 12 of the assay) with
NF200, a primary antibody specific to neurofilaments.
2.6.2. Adipocyte Differentiation Assay. This was carried out
according to established methods [41] and the resulting cul-
tures were stained with oil red O to detect lipid [5].
2.6.3. Endoderm Differentiation Assay. 6 days after their for-
mation, EBs were plated onto 35mm 0.1% gelatin-coated
dishes and maintained in ESC differentiation medium. After
12 more days, with medium changes every second day, the
cells were fixed and stained with antibodies against albumin
and alpha-1-fetoprotein.
2.7. Human ESC and iPSC Culture. The human H9 ESC
line and iPSC established and validated in our laboratory
were used in this study. Cells were grown on mitomycin-
inactivated MEFs with hESC medium containing KnockOut
DMEM, 100μM β-mercaptoethanol, 1mM L-glutamine,
1% nonessential amino acids, 20% serum replacement (Invi-
trogen), 1% penicillin-streptomycin, and 8ng/ml FGF2
(Invitrogen), which was changed daily.
2.8. Culture of hESCs and iPSCs on Dermal Feeder Layers
from Human Skin. Initially, mitomycin-inactivated MEF or
human DP, DS, and SF were seeded at 4 × 105 cells per well
of 6-well culture plates in dermal medium. After 1 day,
hESCs or iPSCs were seeded onto the feeders and fed every
day with hESC medium. hESC and iPSC cells were pas-
saged every 4-5 days by incubation in 1mg/ml collagenase
IV (Invitrogen) at 37°C or mechanically dissociated and then
removed to freshly prepared feeders. Cultures were fixed and
incubated with nitro blue tetrazolium and 5-bromo-4-
chloro-3′-indolyphosphate (NBT/BCIP) substrate solution
to detect alkaline phosphatase activity. For immunocyto-
chemistry analysis, colonies were separated from their
feeders and seeded onto chamber slides coated with ESC-
qualified matrigel in MEF-conditioned hESC medium for 2
days prior to fixation and analysis.
2.9. Flow Cytometry of hESCs. For flow cytometry analysis,
hESCs were collected using collagenase IV treatment
(1mg/ml for 5 minutes) followed by brief accutase incuba-
tion. Cells were suspended in staining buffer (PBS+5%
FCS) at 106 cells/ml. 105 cells were stained with TRA-1-60,
SSEA-4 (Millipore), or Oct4 (Santa Cruz) antibodies at
10μg/ml final concentration. Several washes were carried
out in staining buffer before proceeding to staining with sec-
ondary antibodies. Cells were washed three times and resus-
pended in staining buffer before being analyzed with FACS
Calibur (BD) using CellQuest. 10,000 events were acquired
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for each sample, and propidium iodide staining (1μg/ml)
was used to distinguish live from dead cells.
2.10. Reverse Transcription Polymerase Chain Reaction. Total
RNA from 2D and 3D cocultures, rodent DP and DS cell cul-
tures, mESC cultures with or without LIF, and dissected
vibrissa follicles (end bulb, mid-follicle, and upper follicle)
were prepared using the ToTALLY RNA Kit (Ambion) as
described by the manufacturer.
Contaminating genomic DNA was eliminated by
DNase I digestion (DNA-free kit, Ambion). Approximately
1μg total RNA from each sample was reverse transcribed
(Superscript II RT, Invitrogen) using oligo-dT primers.
PCR was then performed using Taq polymerase (Invitrogen)
with specific primer sets for each gene (Table 1). PCR reac-
tions were carried out as follows: 94°C for 5min; 20–30 cycles
of 94°C for 30 s, gene-specific annealing temperature for 30 s,
and 72°C for 60s; and 72°C for 5min.
2.11. Immunocytochemistry. Cultured cells were fixed in
either methanol (2min, −20°C) or 4% paraformaldehyde in
PBS (10min, room temperature), blocked against nonspecific
binding, and permeabilized with 0.1% triton X prior to incu-
bating with primary antibodies (Table 2) for 1 hr at room
temperature or overnight at 4°C. Following primary antibody
incubation, cells were rinsed in PBS and incubated with
secondary antibodies for 1 hr at room temperature in the
dark. Stained samples were mounted under glass coverslips
in Mowiol (Calbiochem) and visualized with a Zeiss Axiovert
135 microscope. Isolated rat vibrissa follicles were frozen in
OCT (Agar Scientific) in liquid nitrogen or embedded in
paraffin wax after overnight 4°C paraformaldehyde fixation.
Antibodies bound on paraffin-embedded tissues were visu-
alized using the VECTASTAIN ABC-AP kit (goat IgG,
Vector Laboratories).
2.12. Bone Marrow Stromal Cell Culture. Mouse bone
marrow stromal cell (BMSC) primary cultures were estab-
lished as previously described [42]. The S17 stromal cell line
is an immortalized cell line originally isolated from Dexter
culture [43]. Cultures were routinely passaged as previously
Table 1: Primer sets for reverse transcription polymerase chain reaction.
Name Sequence Annealing temp (°C) Size (bp)
GAPDH
F: GCC AAA AGG GTC ATC ATC TC
61 379
R: ACG GAT ACA TTG GGG GTA GG
Oct4
F: CCC GGA AGA GAA AGC GAA CT
58 362
R: GAC GGG AAC AGA GGG AAA GG
Nanog
F: AGG GTC TGC TAC TGA GAT GCT CTG
56 363
R: CAA CCA CTG GTT TTT CTG CCA CCG
LIF
F: ATT GTG CCC TTA CTG CTG CT
61 583
R: GCC TGG ACC ACC ACA CTT AT
CT-1
F: GAG GAA TAC GTG CAG CAA CA
57 389
R: AGC ACC TTG GCT GAG AAG AT
OSM
F: CAC GGC TTC TAA GAA CAC TGC
59 547
R: CGA TGG TAT CCC CAG AGA AA
CNTF
F: CTT TCG CAG AGC AAT CAC CT
61 579
R: CCC CAT AAT GGC TCT CAT GT
BMP2
F: TCC ATC ACG AAG AAG CCG TG
58 465
R: CCA AAA GTC ACT AGC AAT GGC
BMP4
F: AGG GCC AGC ACG TCA GAA TC
57 430
R: ACC TTG TCA TAC TCA TCC AGG
CNTFRα
F: CTG TTT CCA CCG TGA CTC CT
59 802
R: TGG GAC ACT GGT CAA GAA GA
Nodal
F: GCC AGA CAG AAG CCA ACT GTG
61 324
R: TCA GAG GCA CCC ACA CTC CTC
GluR6
F: CTG CAG CAC AGA GAG GAA CCA
60 488
R: ATA ACT TCC TCC ATG TGC CTC AC
Brachyury
F: GCT GAG ACT TGT AAC AAC CG
55 266
R: GCA AAG GAC TCT GAT TAA CTG C
TTR
F: CCG TTC CAT GAA TTC GCG GAT
60 240
R: TTC ACG GCA TCT TCC TGA GC
AFP
F: TTG CCT CCA CGT GCT GCC AGC
61 341
R: CGC CAG CTG CTC CTC TGT CAG
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described and were plated into 35mm dishes at p3 or p4 and
allowed to grow to confluence.
2.13. Isolation and Purification of Haematopoietic
Progenitors. Mice (6-week-old Balb/c) were killed by cervical
dislocation, and bone marrow was collected from their
femurs by flushing with PBS using a 25 g needle and 1ml
syringe. Red blood cells were lysed by incubation for 10
minutes in a hypotonic solution of ammonium chloride
(7.5%) at room temperature, and the remaining nucleated
cells were collected by centrifugation at 2000 rpm and
washed 3 times in PBS. Viability was determined by Trypan
blue exclusion, and cells were counted and resuspended in
PBS. These were separated into c-kit-enriched or depleted
populations by the magnetic activated cell sorter (MACS)
system (Miltenyi Biotec, Bergisch-Gladbach, Germany).
2.14. Stromal Support Experiments. A summary of the strat-
egy for these experiments is shown in the Supplementary
Figure S1. Stromal support experiments used mouse DP
and DS between passage 3 and passage 5 as stromal layers,
with either primary mouse bone marrow stromal cells or
S17 mouse stromal cell line as positive controls. All stro-
mal cells were grown in MEM with 10% FCS. Confluent
stromal layers were seeded with105 unfractionated bone
marrow nucleated cells. Alternatively, they were seeded
with the c-kit-enriched (MACS-bound) population or with
the depleted (MACS-run through) population from 105 bone
marrow nucleated cells. Cocultures were maintained for 28
days, and nonadherent cells were harvested every seven days
and used for CFU-M assays. Experiments were repeated 6
times, cell numbers were entered into Excel, and standard
deviations were calculated using Excel.
2.15. CFU-A Assays. CFU-A assays were performed essen-
tially as previously described [44]. Briefly, support layers
of 0.5ml 0.6% agar in Alpha-MEM (Gibco-Invitrogen)
containing 100μl per ml of conditioned medium from
the cell lines AF1-19T (a source of GM-CSF) and L929
(a source of M-CSF) were plated into the wells of a 24-well
plate. Cells (2000/well) were overlaid in 0.5ml of plating
medium (identical to support layer, but using 0.15% agar).
Plates were cultured for 20 days in 10% CO2, in humidified
incubators. Experiments were repeated 6 times, colony num-
bers were entered into Excel, and standard deviations were
calculated using Excel.
3. Results
3.1. Expansion of mESCs Cocultured on Rodent DP or DS
Cells. When mESCs were cocultured with follicular dermal
cells (Z40 or PVG in origin) in dermal cell medium, we
observed growth of colonies of undifferentiated mESCs sim-
ilar to those formed on MEFs when supplemented with LIF.
The mESCs settled in discrete colonies on top of the dermal
cell monolayer (Figures 1(a), 1(d), and 1(g)) and expressed
EGFP under the control of Rex-1 (undifferentiated mESC
marker, Figures 1(b), 1(e), and 1(h)). The rodent feeder cells
were not mitotically arrested and were either split together
with the mESCs every 2 or 3 days or maintained as a conflu-
ent layer under the mESC colonies. In multiple experiments,
the longest continuous coculture of mESCs with rodent der-
mal cells was either 8 passages or 4 weeks (depending on the
method used) before the cocultures were used for other tests.
When mESCs were grown with rodent SF cultures, colonies
became flatter and less distinct in appearance (Figure 1(a)),
and lost Rex-1-directed GFP expression (Figure 1(b)) and
Oct4 expression (Figure 1(c)). However, irrespective of the
coculture methodology, mES cells grown on follicular der-
mal cells (DP or DS) showed no significant loss of colony
morphology (Figures 1(d) and 1(g)), or Rex-1-directed
GFP expression (Figures 1(e) and 1(h)), or evidence of
differentiation as indicated by the pluripotency marker
Oct4 (Figures 1(f) and 1(i)). After eight or more passages
on rodent DP and DS cells, the expanded mES cells were
separated from their cocultures and analyzed using RT-
PCR for the gene expression of various ES pluripotency
and differentiation markers. High levels of Oct4 and Nanog
expression were detected in mESCs when cultured on DP
and DS cells, but not when cultured without LIF or feeder
layers (Figure 1(j)). mESCs cocultured with DP and DS cells
in dermal medium (particularly with DS cells) did not
express significant levels of differentiation markers such as
Nodal, GLU-R6, Brachyury, AFP, and TTR at any point,
whereas these were highly expressed in mESCs cultured in
ES differentiation medium for 6–14 days.
3.2. The Supportive Role of Rodent DP and DS on mESCs Is
Mediated via Soluble Factors. Having established that plurip-
otent mESCs could be maintained in an undifferentiated
state by follicular dermal cells in coculture, we next investi-
gated if this process was mediated by soluble factors. As pre-
viously observed, there are marked contrasts between mESCs
Table 2: Antibodies used during immunochemical analysis.
Antibody Manufacturer Dilution used
Anti-albumin Dako 1 : 100
Anti-alpha-1-fetoprotein Dako 1 : 100
Anti-α-smooth muscle actin Sigma 1 : 10
Goat anti-CNTF R&D Systems 1 : 40
Anti-GFP Abcam 1 : 100
Anti-gp130 Santa Cruz 1 : 30
Goat anti-LIF R&D Systems 1 : 100
Anti-NF200 Sigma 1 : 100
Anti-OCT-3/4 R&D Systems 1 : 20
Anti-Tra-1-60 Millipore 1 : 200
Anti-Tra-1-81 Millipore 1 : 200
FITC anti-mouse DAKO 1 : 80
TRITC anti-mouse Jackson Immuno 1 : 100
Alexa Fluor 546 anti-mouse Molecular Probes 1 : 500
FITC anti-rabbit DAKO 1 : 100
Alexa Fluor 546 anti-rabbit Molecular Probes 1 : 500
TRITC anti-rat Jackson Immuno 1 : 100
Alexa Fluor 594 anti-rat Molecular Probes 1 : 500
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maintained in complete mESC medium (dense colonies with
just a few differentiated cells) and those cultured in ESC dif-
ferentiation medium (numerous morphological changes)
(Figures 2(a) and 2(b)). When we maintained mESCs in con-
ditioned dermal medium from DP/ES cocultures, we found
that this was most effective at maintaining undifferentiated
mESC morphology, with DS/ES-, DP only-, and DS only-
conditioned media being progressively less effective. How-
ever, in all conditioned medium cultures, a larger proportion
of the mESCs maintained a typical mESC morphology than
in the culture maintained in ESC differentiation medium
(Figure 2(c)), suggesting that soluble factors secreted by the
dermal cells (both in the presence and absence of ESCs) pre-
vent differentiation of ESCs.
3.3. Expression of ES Cell Supporting Cytokines In Vitro and
In Vivo. In an attempt to determine which soluble factors
may be involved in mediating mESC maintenance, RT-PCR
was used to detect transcripts of potential candidates known
to be involved in mESC support; Nanog, Oct4, LIF, CNTF,
OSM, and CT-1 expression was examined in DP, DS, and
BMSC which has previously been shown to support the
expansion of undifferentiated ESCs [13]. Members of the
bone morphogenetic family (BMP) have also been implicated
in mESC regulation in combination with LIF [45]. BMP2 was
detected in DP and DS cells, while BMP4 expression was typ-
ically lower in DP cells when compared with DS and BMSC
(Figure 2(d)). Cultured rodent DP and DS cells expressed
higher levels of LIF, CT-1, Nanog, and CNTF than BMSC,
while Oct4 (at low levels) and OSM expression was seen in
BMSC, but not in dermal cells. Conversely, Nanog was
expressed in DP and DS cells but was not detectable in
BMSC (Figure 2(d)).
To examine the in vivo expression of cytokines of inter-
est, mid-anagen vibrissa follicles dissected from three Zin40
mice were used as a source of RNA. CNTF, LIF, CT-1, and
the receptor component CNTFRα were expressed in all
regions of mid-anagen follicles, whileOSMwas not expressed
at comparable levels (Figure 2(e)). We investigated the local-
ization of a subset of these cytokines in intact follicles by
immunohistochemistry, and interestingly, we found that
localization of LIF (Figure 2(f)) and CNTF (Figure 2(g))
was not only confined to dermal cell populations. Indeed,
rather than being highly expressed in the DP and DS, LIF
appeared to be concentrated in the epithelium immediately
surrounding the DP, whereas CNTF appeared to have a more
general distribution, with localized expression in the upper
third of the DP and lower DS, coupled with higher levels of
epithelial localization. Since the IL-6 family cytokines inves-
tigated here all act through a receptor complex containing
gp130, we also examined gp130 distribution in intact follicles
(Figure 2(h)). Again, this was present predominantly in the
epithelial layers of the follicle, with distinct expression at
the DP/epithelial boundary. Specifically in the bulge region
higher up the follicle (Figure 2(i)), the epithelial cells showed
strong gp130 immunolabelling (Figure 2(i∗)).
3.4. Follicular Dermal Cells Are Unable to Prevent ES Cell
Differentiation in 3-Dimensional Cultures. Having demon-
strated that follicular dermal cells are able to inhibit mESC
differentiation in 2D cultures, we next investigated if they
can prevent differentiation of mESCs in 3D cultures. EBs
were produced containing either mESCs only or a 1 : 1, 3 : 1,
or 10 : 1 ratio of follicular dermal to mESCs by hanging drop
culture. During the early stages of EB culture (2–4 days), it
was noted that the inclusion of follicular dermal cells tended
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Figure 1: Maintenance of mESCs by rodent hair follicle dermal cells. Rex-1 EGFP-transfected CGR8 mESCs were cocultured with PVG
fibroblasts (a–c), DP (d–f), and DS (g–i) cells. The ESCs lost colony morphology (a), Rex-1-directed EGFP expression (b), and Oct4
expression (c) when cultured with skin fibroblasts. However, mESCs were effectively maintained in an undifferentiated state by coculture
with follicular dermal cells, both DP and DS, displaying compacted colonies (d, g), eGFP expression under the control of Rex-1 (e, h), and
high levels of Oct4 expression (f, i). RT-PCR analysis of CGR8 mESCs cocultured with rat DP and DS cells (j). PCR products obtained
using primers specific for mouse GAPDH (control), Oct4, Nanog (markers of undifferentiated ES cells), LIF, BMP4 (involved in ES
support), Nodal, Glu-R6, Brachyury, TTR, and AFP (markers of differentiation). Scale bars = 50 μm.
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to modulate EB formation, with EB’s containing DP or DS
cells being less regularly shaped than those comprising
mESCs alone, and often, with more than one EB forming in
each hanging drop (Figure 3(a)). Once EBs were transferred
to suspension culture, they continued to grow for 9–12 days,
often producing large cysts containing cardiomyocyte-like
(beating) cells. We found that this remained the case no mat-
ter how many dermal cells were included, although a higher
proportion of dermal cells generally resulted in smaller cysts.
Follicular dermal cells alone were unable to form cysts
and instead were maintained as tight clumps of cells with
little or no increase in size. Within EBs, it appeared that
dermal cells were not well distributed and instead were
remaining aggregated (Figure 3(b)). Surprisingly, however,
in all cases, the mESCs rapidly outgrew the dermal cells and
expressed differentiation markers not present in 2D cocul-
tures (Figure 3(c)). We found that neither the addition of
LIF nor the addition of an increasing proportion of dermal
cells to the EBs could prevent this (data not shown); so, for
all subsequent experiments, we used a 1 : 1 ratio of derma-
l : ESCs for EB formation. The mESCs rapidly lost expression
of Oct4 and Nanog, further confirming that undifferentiated
mESCs were not maintained, although LIF expression was
not substantially downregulated. We found that the pattern
of differentiation markers expressed varied from that shown
by differentiated mESCs in 2D culture (compare Figures 1(j)
and 3(c), ESC only), with no evidence of GluR6 expression
and significant loss of BMP4 expression by mESCs in the
3D cultures.
3.5. Cocultured mESCs Maintain Differentiation Potential in
Culture. When mESCs were directly differentiated in the
neuronal differentiation assay, we observed networks of
neuron-like cells after 12 days in culture. Axon-like projec-
tions extended in networks from EBs, which in association
with other cell types adhered to the culture substrate
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Figure 2: Dermal cells provide support for mESCs via soluble factors. mESCs were cultured in complete mESC medium (a), ESC
differentiation medium (b), and DP/mESC coculture conditioned medium (c) for 10 days. Cultures maintained in conditioned medium
showed maintenance of typical mESC colony morphology and behaviour. (d) Cytokines known to be involved in mESC maintenance are
expressed by follicular DP, DS, and BMSC. (e) Several of these cytokines are also expressed in different regions of vibrissa follicles as
detected by PCR. However, the localization of LIF (f), CNTF (g), and gp130 (h) by immunohistochemistry (pink staining) in the
lower follicle bulb region shows that they are predominantly in the follicle epithelium. (i) gp130 is also expressed in the upper
follicle (i) specifically in the bulge epithelium (i∗) (region delineated by a yellow rectangle) (CL: club hair; GH: growing hair). Scale
bars (a–i) = 100μm and (i∗) = 50 μm.
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Figure 3: Coculture of dermal cells and mESCs in embryoid bodies
does not prevent differentiation. (a) Embryoid-like bodies formed
after 3 days in hanging drop culture. Follicular dermal cells were
stained with DiI and mESCs expressing GFP under the control
of the CAGG promoter. Hanging drops containing follicular
dermal cells produced EBs having several foci of aggregation, in
contrast to those containing ES cells alone. (b) EBs after 9 days in
suspension culture. EBs containing mESCs were much larger than
those with only follicular dermal cells. (c) Differentiation markers
expressed by mESCs in 3 dimensional cocultures with follicular
dermal cells. Scale bars (a) = 50 μm and (b) = 100 μm.
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(Figure 4(a)). Cells originating from cocultures with PVG
and Z40, DP, and DS cells all gave positive results in this
assay, with a minimum of 65% of EBs producing networks
of neuron-like cells.
The greatest numbers of neuronal outgrowths were
observed in cells originating from 6 day Z40 DS :mESC
cocultures where 90% of EBs had neuron-like cells associ-
ated with them. Immunocytochemistry for neurofilament
markers confirmed these cells to be neuronal, and coloca-
lization with GFP also confirmed that they were derived
from mESCs (Figure 4(b)).
In the adipocyte differentiation assay, mESCs isolated
from PVG and Z40, DP, and DS cocultures gave consistently
positive results. Throughout experimental cultures, oil red O
staining showed small lipid droplets and large lipid-filled
cells in patches ranging from a few cells to up to 50 cells
closely packed together (Figure 4(c)). Approximately 30%
of each culture exhibited high levels of lipid deposition.
In the endoderm differentiation assay, mESCs from all
cocultures gave positive results. Small clusters of GFP-
positive CGR8-GFP cells were immunoreactive for albu-
min (Figure 4(d)) and alpha-feta-1-protein (Figure 4(e)).
As expected, these comprised no more than 1% of the
total cell population.
3.6. Maintenance of hESCs and iPSCs by Hair Follicle Dermal
Feeder Layers. After demonstrating that mESCs were main-
tained in an undifferentiated state by coculture with follicular
dermal cells, we next asked if human hair follicle dermal
cells could act as effective feeders for hESCs and iPSCs.
When we cultured hESCs on mitotically inactive human
DP or DS feeders for multiple passages, high levels of
SSEA-4, TRA-1-60, and OCT4 expression were maintained,
as determined by flow cytometry (Figure 5(a)). Although all
DP and DS lines tested were able to maintain hESCs express-
ing high levels of these markers, it was evident that some lines
were more effective than others. Immunolabelling of DP-
supported hESCs with antibodies to NANOG and OCT4
showed levels of staining equivalent to those shown by hESCs
cultured with MEFs (Figures 5(b)–5(e)). Subsequently, when
we cultured human iPSCs on mitotically inactivated MEFs
(Figures 6(a)–6(d)), human SF (Figures 6(e)–6(h)), DP
(Figures 6(i)–6(l)), or DS (Figures 6(m)–6(p)), we found that
they maintained a typical hESC-like appearance on the follic-
ular dermal feeders, in discrete colonies with a high nuclear
to cytoplasmic ratio. iPSC grown onMEFs, DP, or DS feeders
for several passages remained positive for the pluripotency
markers alkaline phosphatase, Tra-1-60, and Tra-1-81. Com-
paratively, expression of these markers was lost in iPSCs after
a short period of growth on interfollicular SF feeders.
3.7. Hair Follicle Dermal Cells Support Haematopoietic
Progenitors. All stromal cell types appeared to support
haematopoietic cells, as indicated by the typical cobblestone
morphology of the cells on the surface of the cultures
(Supplementary Figure S2).
Cell counts revealed that DP and DS cultures were at least
as effective as bone marrow stroma and S17 cell lines in sup-
porting the proliferation of nonadherent cells in coculture
experiments (Figure 7(a)). This was particularly the case for
unfractionated or c-kit-enriched populations. Flow cytome-
try with CD45 confirmed that haematopoietic cells were
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Figure 4: mESCs maintain pluripotency after coculture with dermal cells. (a) Networks of neurons extend from EBs derived from mESCs
after 6-day coculture with PVG rat DS cells. (b) GFP mESCs after 6-day coculture with PVG DP cells produce neuron-like cells; the
projections of which are visible by fluorescence microscopy. Immunostaining with anti-NF200 antibodies demonstrates expression of
neurofilament (red) and the colocalization with the GFP fluorescence (green). (c) ESCs cocultured with PVG DS for 6 days produced high
levels of lipid (red). One EB in particular was observed to be producing copious amounts of lipid. Endodermal cells are present in
differentiated cells from 6-day cocultures of GFP mESCs with PVG DP (d) and Z40 DP (e). Green fluorescence identifies the cells as being
of mESC origin while red fluorescence shows immunoreactivity for albumin (d) and AFP (e). Scale bars (a) = 200 μm, (b–e) = 50 μm, and
(d) = 25 μm.
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being produced (data not shown), but this could have been
due to mitosis of mature cell types. In order to investigate
whether haematopoietic progenitors were being supported
by the stromal cultures, the nonadherent cells were subjected
to colony assay using CFU-A. Figure 7(b) shows that the
number of CFU-A colonies produced following coculture
with DP or DS cultures appeared greater than that from con-
ventional Dexter-type bone marrow stromal cell culture. This
increase in haematopoietic progenitor number was especially
marked for the c-kit-enriched population.
4. Discussion
The initial hypothesis for the current work was that follicular
dermal cells, when cocultured with pluripotent ESCs, might
induce differentiation along the lineage of follicular epithelial
cells. The inductive capacity of hair follicle dermal cells has
been well documented [1, 2]. Nonfollicular epithelium will
form follicles when associated with DP cells or embryonic
dermis from hairy skin [3, 4], demonstrating the ability of
DP cells to direct the differentiation of cells in close proxim-
ity, as is believed to be their physiological role in the adult
hair follicle [1, 46]. In our hands, rat vibrissa follicle dermal
papilla cells lose this inductive capacity around passage 4 in
culture [47]. It has been shown that ESCs differentiate along
both dermal and epidermal lineages to produce a tissue
equivalent to embryonic skin when exposed to factors pro-
duced by skin fibroblasts [48]; so, it seemed reasonable to
postulate that follicular dermis would induce differentia-
tion along follicular lineages. In contrast to the working
hypothesis, follicular dermal cells maintained both rodent
and human ESCs and iPSCs in an undifferentiated state
after long-term coculture. As both pre- and postinductive
rat dermal papilla cultures showed the same influence on
ES cells, it appeared that this phenomenon was not linked
to loss of DP-inductive properties. The colonies of mESCs
produced, either in mixed cocultures or in cultures where the
dermal and ESCs were not in contact, were identical to those
maintained by LIF or an MEF feeder layer (as confirmed by
TEM (data not shown), immunocytochemistry, RT-PCR,
and the use of Rex 1-EGFP CGR8 cells). Both human and
mouse ESCs retained high levels of intrinsic Oct4 and Nanog
expression, which are known to maintain pluripotency both
in vivo and in vitro [49–51]. Human iPSCs cultured on follic-
ular dermal cell feeders also retained high levels of the cell
surface antigens Tra-1-60 and Tra-1-81, comparable to the
levels expressed by iPSCs grown on MEF’s, demonstrating
that undifferentiated iPSCs can be effectively maintained by
follicular dermal cells (both DP and DS). These markers of
undifferentiated hESCs disappear rapidly upon differentia-
tion [52], as was seen when the cells were grown on control
fibroblast feeder layers. We also showed that mESCs retained
their pluripotency after coculture by performing differentia-
tion assays to induce differentiation into cell lineages derived
from each of the three germ layers. The observation that in
3D coculture, follicle dermal cells were unable to prevent
ES cell differentiation typical of embryoid bodies reflects
the powerful influence of the 3D environment on ES behav-
iour and the fact that there was segregation of the two cell
types within the structures. It may also be that in 3D, the der-
mal cells had a different secretory profile.
The behaviour of mESCs exposed to dermal cell- or
coculture-conditioned media in 2D, or in cultures where
the cells were physically separated by a 0.45μM filter,
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Figure 5: Follicular dermal cells support hESCs. hESCs cocultured with either MEFs, human DP cells, or human DS cells showed comparable
levels of expression of SSEA-4, TRA-1-60, and Oct4 (a), as determined by flow cytometry indicating that the DP and DS cells were as capable
of maintaining hESCs in an undifferentiated state as MEFs. Although all DP and DS cell lines tested were able to maintain hESCs expressing
high levels of these markers, it was evident that some lines were more effective than others. hESCs maintained by MEFs and labelled for
NANOG (b) and OCT4 (c) have similar staining to hESCs maintained by DP cells and labelled for NANOG (d) and OCT4 (e). Scale
bars = 100μm.
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indicated that soluble factors were present in the media
secreted by the dermal cells (both in the presence and in
the absence of ESCs), with the capacity to inhibit differentia-
tion. A similar study identified secreted factors in MEF-
conditioned medium that could maintain undifferentiated
hESCs in the absence of feeder cells [53]. Four members of
the IL-6 family of cytokines (LIF, CNTF, CT-1, and OSM)
have been shown to maintain undifferentiated mESCs
in vitro via the LIFR/gp130/STAT pathway [24, 54–58].
Therefore, we interrogated the mRNAs of cultures and found
that transcripts of three of these cytokines, LIF, CNTF, and
CT-1 were detected in dermal cells. Additionally, BMPs are
known to cooperate with LIF to maintain mESC pluripotency
[45], and BMP2 and BMP4 were detected in the hair follicle
dermal cell culture. We also found that cultured DP and DS
expressed Nanog, a downstream effector of the LIF/STAT3
pathway in maintaining mESC pluripotency [49]. Further,
undifferentiated hESCs can be maintained without feeder
cells by the presence of high levels of Nanog [51]. The expres-
sion of these cytokines in vitro raises the intriguing possibility
that they may play a functional role in vivo. The localiza-
tion of LIF and CNTF in the follicle end bulb suggests
that they are physiologically relevant. Past studies have
cited them as promoters and inhibitors of both differenti-
ation and proliferation [27, 24, 54–57, 59–61], processes
that occur predominantly in the follicle end bulb and are
key to the cyclic nature of hair follicle activity. Moreover,
we noted strong gp130 expression in the bulge region of
the follicle outer root sheath, which houses the main epi-
thelial stem cell population of the hair follicle. However,
the relative lack of cytokine expression in the dermal
papilla cells of the follicle bulb, but the presence of LIF,
CNTF, and CT-1 mRNA in all segments of the mid-
anagen follicle, indicates a widespread function within fol-
licles, rather than a specific role in follicular epithelial stem
cell maintenance. Similarly, the expression of CNTFRα
mRNA throughout the follicle suggests that members of
the IL-6 family are unlikely to be involved specifically in
maintenance of stemness in the surrounding epithelial cells
by the follicular dermis. It appears that the mechanisms by
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Figure 6: Hair follicle dermal cells maintain human iPSCs in an undifferentiated state. Human iPSCs were grown on either MEF, human SF,
DP, or DS cells. On MEFs, iPSCs maintained normal ESC-like morphology (a), high alkaline phosphatase (b), Tra-1-60 (c), and Tra-1-81 (d)
expression. In comparison, when grown on fibroblast feeders, the iPSC colonies became less compact (e), and with increasing passage number
lost expression of pluripotency markers and alkaline phosphatase (f–h). When grown on hair follicle dermal cells, DP (i–l), but particularly
DS (m–p), the iPSCs maintained normal ESC morphology and high levels of expression of ESC pluripotency markers for several passages in
culture. Scale bars = 100μm.
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which the dermal cells support ES cell maintenance have no
obvious parallels with regulation of epithelial stem cell activ-
ities in the follicle. The contribution of the above cytokines to
various aspects of hair follicle biology remains to be fully
defined although there are reported connections between
the gp130/JAK/STAT pathway and follicle activities.
Interleukin-6 itself has been linked with hair growth inhibi-
tion and follicle regression [62, 63]. Moreover, in mice,
JAK-STAT3 signalling is needed for the initiation of sponta-
neous anagen [64]. Stat5 activation in the follicle DP has
recently been shown to trigger follicle entry in the growing
phase (anagen) [65], and one of us (AMC) has recently shown
that pharmacologically inhibiting the JAK/STAT pathway
induced anagen from resting (telogen) follicles [66].
The elimination of animal material during both the deri-
vation and long-term culture of hESCs or iPSCs is an impor-
tant goal prior to application of these cells for clinical
therapy. Animal-derived feeders and serum risk the intro-
duction and transfer of nonhuman pathogens to human cells
and increase the the risk of graft rejection when cells are
introduced into patients [67,68].
A wide range of feeder cell types, conditioned media, and
feeder-free systems has been investigated [25, 34], including a
xeno-free system for derivation of hESCs using human serum
and a human foreskin fibroblast feeder layer [69]. Human
hair follicle dermal cells could be similarly utilized for both
hESC derivation and long-term maintenance. Moreover,
iPSCs have recently been derived from mouse hair follicle
DP cells using a single transcription factor [70], and we
have derived iPSCs from human hair follicle DP cells
[71]. A recent report has shown that human follicle dermal
(mesenchymal) cells maintain hES cells in an undifferenti-
ated condition [72]. Our work supports this finding and
extends it to human iPS cells. Therefore, follicle dermal cells
may parallel the properties of human and mouse adipose-
derived cells that can be used both to establish iPSCs in a
feeder-independent manner and as feeder cells for support-
ing different pluripotent stem cells [73].
Previous studies have shown strong parallels between
hair follicle dermal cells and bone marrow cells [17]. There-
fore, our findings here that hair follicle dermal cells support
haematopoiesis are to some extent unsurprising. However,
the dermal cells were apparently equal to and possibly supe-
rior to bone marrow cells as stromal supports. Since we pre-
viously demonstrated that cultured hair follicle dermal cells
can produce colonies in CFU-A assays and restore haemato-
poiesis in irradiated mice [8], this raises the question as to
what extent the follicle dermal cells were contributing to
the haematopoietic pool. This was not explored here and
would need future work. Notwithstanding this, adipose-
derived MSCs have also been reported to support haemato-
poiesis better than bone marrow cells [74]. A feature of the
adipose cells was their expression of CXCL12 (SDF-1) a
key regulator of haematopoiesis, which is also strongly
expressed by cultured hair follicle dermal cells (see Supple-
mentary Figure S2). It would be surprising if hair follicle
dermal cells were to be routinely adopted for support of
pluripotent human cells given the direction of travel
towards feeder-free methods [25–31] and the availability
of alternative human candidate cell types [32–35]. How-
ever, follicle dermal cells do fulfill important criteria,
including being easily accessible, readily propagated, and
efficient at maintaining undifferentiated hESCs. Moreover,
where there is a clinical role for support cells in transplan-
tation, as in haematopoiesis [74, 75], follicle dermal cells
have an advantage. These cells are in the process of being
exploited for use in the production of new follicles in the
treatment of alopecia and the creation of improved skin
grafts. Therefore, work on the safe bioprocessing of these
cells for clinical transplantation is already in train, making
their eventual use in the context of stem cell support a more
plausible proposition.
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Figure 7: Hair follicle dermal cells support haematopoietic activity in coculture with murine bone marrow cells. (a) Total numbers of
nonadherent cells produced by coculture of murine bone marrow cells with different stromal support cells over a 28-day period.
N = 6 ± SD. (b) CFU-A colony production by coculture of murine bone marrow cells with stromal cells. Total burst colonies
produced per sample over a 28-day period. No colonies were produced from c-kit fractions for any stromal condition. N = 6± SD.
S-17: an immortalized stromal cell line; BMSC: bone marrow stromal cells; DP: dermal papilla cells; DS: dermal sheath cells.
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5. Conclusions
Here, we have demonstrated that coculture of hair follicle
dermal cells with ESCs or iPSCs can support their long-
term maintenance. We further show that the follicle cells
support haematopoietic activity. This could have potential
benefit in a clinical context, where the elimination of animal
feeder layers is necessary prior to application of pluripotent
cells for therapy and where the application of mesenchymal
stem cell-like populations goes beyond their own direct
therapeutic use, to include a role as support cells for other
transplantable cell types.
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